Benzinga | Jan 11, 2022 04:21PM EST

Biogen Shares Down After Hours Following US Centers For Medicare Listing For 'Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease'

https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&ncaid=305&ncacaldoctype=all&status=all&sortBy=status&bc=17